Correlation Between Abionyx Pharma and Quantum Genomics

Can any of the company-specific risk be diversified away by investing in both Abionyx Pharma and Quantum Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abionyx Pharma and Quantum Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abionyx Pharma SA and Quantum Genomics SA, you can compare the effects of market volatilities on Abionyx Pharma and Quantum Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abionyx Pharma with a short position of Quantum Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abionyx Pharma and Quantum Genomics.

Diversification Opportunities for Abionyx Pharma and Quantum Genomics

-0.15

Correlation Coefficient

Abionyx Pharma  Quantum Genomics

Good diversification

The 3 months correlation between Abionyx and Quantum is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Abionyx Pharma SA and Quantum Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Genomics and Abionyx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abionyx Pharma SA are associated (or correlated) with Quantum Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Genomics has no effect on the direction of Abionyx Pharma i.e., Abionyx Pharma and Quantum Genomics go up and down completely randomly.

Pair Corralation between Abionyx Pharma and Quantum Genomics

Assuming the 90 days trading horizon Abionyx Pharma SA is expected to generate 1.12 times more return on investment than Quantum Genomics. However, Abionyx Pharma is 1.12 times more volatile than Quantum Genomics SA. It trades about -0.01 of its potential returns per unit of risk. Quantum Genomics SA is currently generating about -0.05 per unit of risk. If you would invest  123.00  in Abionyx Pharma SA on October 3, 2024 and sell it today you would lose (4.00) from holding Abionyx Pharma SA or give up 3.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Abionyx Pharma SA  vs.  Quantum Genomics SA

Abionyx Pharma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Abionyx Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Abionyx Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Quantum Genomics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Quantum Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Abionyx Pharma and Quantum Genomics

The main advantage of trading using opposite Abionyx Pharma and Quantum Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abionyx Pharma position performs unexpectedly, Quantum Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Genomics will offset losses from the drop in Quantum Genomics' long position.

The idea behind Abionyx Pharma SA and Quantum Genomics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.